AMRA originated with precision medicine in mind, understanding that to effectively target our greatest global health challenges, we need a precise, cost-effective way to understand our bodies far beyond what is available today. AMRA is a ground-breaking, international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, alongside contextual disease insights – all from a single, rapid, whole-body MRI. AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making, from clinical research to health and wellness. AMRA’s current research and application areas include Obesity, CVD, Diabetes, NAFLD/NASH, Oncology, Sarcopenia, Cachexia, CNS/Neuromuscular and Musculoskeletal Disorders, and Rare Diseases - in both adult and pediatric populations. For more information, please visit www.amramedical.com or e-mail us directly at info@amramedical.com